Polychronis Antonitsis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Polychronis Antonitsis has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
Kyriakos Anastasiadis
Aristotle University of Thessaloniki School of Medicine
23 shared publicationsHelena Argiriadou
AHEPA University Hospital
21 shared publicationsApostolos Deliopoulos
Aristotle University of Thessaloniki School of Medicine
17 shared publications- Kyriakos Anastasiadis
Cardiothoracic Department, Aristotle University of Thessaloniki,School of Medicine, AHEPA University Hospital, Thessaloniki, Greece
6 shared publications Cyril Serrick
Peter Munk Cardiac Centre, Toronto General Hospital , Toronto
4 shared publications- Ignazio Condello
School of Medicine and Surgery, University of Insubria, Varese, Italy
4 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 604
Echocardiographic Ventricular Strain Imaging Reflects Alterations in Myocardial Mechanics During and After Cardiac Surgery
Assessment of ventricular function during and post cardiac surgery remains challenging, as conventional echocardiographic indices may not adequately capture subtle and dynamic changes in myocardial performance. Speckle-tracking echocardiography, particularly left ventricular global longitudinal strain (LV GLS) and right ventricular longitudinal strain, provides a more sensitive assessment of myocardial deformation and has increasingly been applied in the perioperative setting. Available studies indicate that LV GLS may deteriorate following cardiopulmonary bypass (CPB) and cardiac surgical intervention despite relatively preserved left ventricular ejection fraction, highlighting the ability of deformation imaging to detect myocardial dysfunction that may remain undetected by conventional parameters. Right ventricular longitudinal mechanics may also undergo substantial perioperative alterations, reflecting the particular susceptibility of the right ventricle to changes in loading conditions, pulmonary vascular resistance, and ventricular interdependence. Importantly, perioperative strain measurements should be interpreted in the context of the cardiovascular effects of general anesthesia and mechanical ventilation, that may alter preload, afterload, and myocardial contractility. The potential influence of anesthetic technique and depth on myocardial deformation represents an emerging research question requiring further investigation. This narrative review synthesizes current evidence on alterations in left and right ventricular strain and cardiac mechanics in patients undergoing cardiac surgery, with particular emphasis on perioperative changes observed in CABG and valve surgery and on the effects of general anesthesia and mechanical ventilation. By integrating findings across these perioperative stages, it aims to highlight the pathophysiological and procedural factors that should be considered when interpreting myocardial deformation, including anesthesia, altered loading conditions, CPB, and the surgical intervention itself.
- 17 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 604
Open AccessEchocardiographic Ventricular Strain Imaging Reflects Alterations in Myocardial Mechanics During and After Cardiac Surgery
Assessment of ventricular function during and post cardiac surgery remains challenging, as conventional echocardiographic indices may not adequately capture subtle and dynamic changes in myocardial performance. Speckle-tracking echocardiography, particularly left ventricular global longitudinal strain (LV GLS) and right ventricular longitudinal strain, provides a more sensitive assessment of myocardial deformation and has increasingly been applied in the perioperative setting. Available studies indicate that LV GLS may deteriorate following cardiopulmonary bypass (CPB) and cardiac surgical intervention despite relatively preserved left ventricular ejection fraction, highlighting the ability of deformation imaging to detect myocardial dysfunction that may remain undetected by conventional parameters. Right ventricular longitudinal mechanics may also undergo substantial perioperative alterations, reflecting the particular susceptibility of the right ventricle to changes in loading conditions, pulmonary vascular resistance, and ventricular interdependence. Importantly, perioperative strain measurements should be interpreted in the context of the cardiovascular effects of general anesthesia and mechanical ventilation, that may alter preload, afterload, and myocardial contractility. The potential influence of anesthetic technique and depth on myocardial deformation represents an emerging research question requiring further investigation. This narrative review synthesizes current evidence on alterations in left and right ventricular strain and cardiac mechanics in patients undergoing cardiac surgery, with particular emphasis on perioperative changes observed in CABG and valve surgery and on the effects of general anesthesia and mechanical ventilation. By integrating findings across these perioperative stages, it aims to highlight the pathophysiological and procedural factors that should be considered when interpreting myocardial deformation, including anesthesia, altered loading conditions, CPB, and the surgical intervention itself.
- 19 August 2026
- Published by SAGE Publications in Perfusion
Factors contributing to thrombocytopenia after cardiac surgery; towards defining coagulation-friendly cardiac surgery
Introduction: The anticoagulation strategy and the cardiopulmonary bypass management represent two core elements of the intraoperative care of the cardiac surgery patient. The ideal approach remains an issue of debate, though data encourage the development of a coagulation friendly environment. Our aim was to investigate the effect of intraoperative management on postoperative thrombocytopenia in cardiac surgery patients. Methods: This is a retrospective study set at a tertiary university hospital. Patients who underwent valve and complex cardiac surgery from January 2019 to December 2021 were included. All patients were managed with Minimally Invasive Extracorporeal Circulation. Platelet count, the anticoagulation technique, hemoglobin, transfusion and bleeding data were recorded perioperatively. Results: A total of 65 patients met the inclusion criteria and were analysed. Postoperatively platelet count decreased from 208 (84) to 169 (63) ( p < 0.001), while at 48 hours 7 patients had a platelet count 9 .l −1 . According to regression analysis, CPB duration and total heparin dose were independent predictors of platelet count whereas no significant correlation was found for protamine dose. After selecting for the anticoagulation technique, patients who received heparin concentration monitoring had significantly lower relative decline in platelet count at 48 hours ( p = 0.04), received a higher total heparin dose ( p = 0.03) but were given less protamine ( p < 0.001). Overall, the frequency of transfusion was low and a trend toward less RBC transfusion was recorded when heparin-level concentration was used ( p = 0.051). Conclusions: Strict heparin-level concentration monitoring combined with Minimally Invasive Extracorporeal circulation may have contributed to a coagulation-friendly cardiac surgery translating into a low incidence of thrombocytopenia and transfusions.
- 19 August 2026
- Published by SAGE Publications in Perfusion
Factors contributing to thrombocytopenia after cardiac surgery; towards defining coagulation-friendly cardiac surgery
Introduction: The anticoagulation strategy and the cardiopulmonary bypass management represent two core elements of the intraoperative care of the cardiac surgery patient. The ideal approach remains an issue of debate, though data encourage the development of a coagulation friendly environment. Our aim was to investigate the effect of intraoperative management on postoperative thrombocytopenia in cardiac surgery patients. Methods: This is a retrospective study set at a tertiary university hospital. Patients who underwent valve and complex cardiac surgery from January 2019 to December 2021 were included. All patients were managed with Minimally Invasive Extracorporeal Circulation. Platelet count, the anticoagulation technique, hemoglobin, transfusion and bleeding data were recorded perioperatively. Results: A total of 65 patients met the inclusion criteria and were analysed. Postoperatively platelet count decreased from 208 (84) to 169 (63) ( p < 0.001), while at 48 hours 7 patients had a platelet count 9 .l −1 . According to regression analysis, CPB duration and total heparin dose were independent predictors of platelet count whereas no significant correlation was found for protamine dose. After selecting for the anticoagulation technique, patients who received heparin concentration monitoring had significantly lower relative decline in platelet count at 48 hours ( p = 0.04), received a higher total heparin dose ( p = 0.03) but were given less protamine ( p < 0.001). Overall, the frequency of transfusion was low and a trend toward less RBC transfusion was recorded when heparin-level concentration was used ( p = 0.051). Conclusions: Strict heparin-level concentration monitoring combined with Minimally Invasive Extracorporeal circulation may have contributed to a coagulation-friendly cardiac surgery translating into a low incidence of thrombocytopenia and transfusions.
- 19 May 2026
- Published by SAGE Publications in Perfusion
Minimal invasive extracorporeal circulation represents a dominant technique in coronary artery bypass grafting; insights from a cost-utility economic analysis
Introduction: To evaluate the cost-utility of minimal invasive extracorporeal circulation (MiECC) versus conventional cardiopulmonary bypass (cCPB) in coronary artery bypass grafting (CABG) over a 7-years horizon. Method: A cohort-based, deterministic cost-utility model was constructed from the Greek NHS perspective over a 7-year period. Clinical inputs were derived from a meta-analysis including 4849 patients. Direct medical costs for intensive care unit (ICU) and ward stay, blood transfusions, intra-aortic balloon pump (IABP) use, and perfusion circuits were applied to estimate the cost of care. Quality of life was quantified in terms of quality-adjusted life years (QALYs) by mapping SF-36 data to EQ-5D utilities. Deterministic sensitivity analyses were used to test key assumptions and a probabilistic sensitivity analysis assessed overall result robustness. Results: MiECC was associated with improved clinical outcomes, including lower perioperative mortality and complication rates, shorter mechanical ventilation duration, and reduced lengths of ICU and ward stay. Over 7 years, patients operated on MiECC accrued 2.21 QALYs versus 2.18 QALYs for cCPB. MiECC dominated cCPB, yielding both cost savings (ΔCost = −1369€) and a QALY gain (ΔQALY = +0.03). Sensitivity analysis confirmed the robustness of the default results under all tested scenarios. Conclusions: In an era focused on value-based care, cardiac centers and healthcare authorities should consider the integration of MiECC as a standard perfusion strategy in coronary surgery, given the supportive evidence of improved morbidity and mortality outcomes without financial impact concerns.
- 19 May 2026
- Published by SAGE Publications in Perfusion
Minimal invasive extracorporeal circulation represents a dominant technique in coronary artery bypass grafting; insights from a cost-utility economic analysis
Introduction: To evaluate the cost-utility of minimal invasive extracorporeal circulation (MiECC) versus conventional cardiopulmonary bypass (cCPB) in coronary artery bypass grafting (CABG) over a 7-years horizon. Method: A cohort-based, deterministic cost-utility model was constructed from the Greek NHS perspective over a 7-year period. Clinical inputs were derived from a meta-analysis including 4849 patients. Direct medical costs for intensive care unit (ICU) and ward stay, blood transfusions, intra-aortic balloon pump (IABP) use, and perfusion circuits were applied to estimate the cost of care. Quality of life was quantified in terms of quality-adjusted life years (QALYs) by mapping SF-36 data to EQ-5D utilities. Deterministic sensitivity analyses were used to test key assumptions and a probabilistic sensitivity analysis assessed overall result robustness. Results: MiECC was associated with improved clinical outcomes, including lower perioperative mortality and complication rates, shorter mechanical ventilation duration, and reduced lengths of ICU and ward stay. Over 7 years, patients operated on MiECC accrued 2.21 QALYs versus 2.18 QALYs for cCPB. MiECC dominated cCPB, yielding both cost savings (ΔCost = −1369€) and a QALY gain (ΔQALY = +0.03). Sensitivity analysis confirmed the robustness of the default results under all tested scenarios. Conclusions: In an era focused on value-based care, cardiac centers and healthcare authorities should consider the integration of MiECC as a standard perfusion strategy in coronary surgery, given the supportive evidence of improved morbidity and mortality outcomes without financial impact concerns.
- Open Access
- 24 March 2026
- Published by Springer Nature in Heart Failure Reviews
- Vol. 31 (1) , 44
Mechanical circulatory support in cardiogenic shock: a contemporary head-to-head comparison
Modern technology has expanded the armamentarium of temporary mechanical circulatory support devices implemented for hemodynamic stabilization of patients in cardiogenic shock. The predominately used ones are intra-aortic balloon pump (IABP), Impella devices, and extracorporeal life support (ECLS) circuits. They are transcutaneous or surgically implanted, utilized for up to 30 days and can either assist or totally replace cardiac function, providing time for myocardial healing (bridge to recovery) or treatment escalation (bridge to destination therapy, bridge to transplantation). In light of the recently published joint consensus of the Perioperative Quality Initiative and Enhanced Recovery After Surgery Cardiac Society on temporary mechanical circulatory support, purpose of the current review is to provide a succinct head-to-head comparison of widely available devices, as well as current escalation, de-escalation and antithrombotic protocols; thus, it proposes immediately translatable device selection and operation algorithms to medical professionals for optimal patient care and effective management of cardiogenic shock.
- 24 March 2026
- Published by Springer Nature in Heart Failure Reviews
- Vol. 31 (1) , 44
Open AccessMechanical circulatory support in cardiogenic shock: a contemporary head-to-head comparison
Modern technology has expanded the armamentarium of temporary mechanical circulatory support devices implemented for hemodynamic stabilization of patients in cardiogenic shock. The predominately used ones are intra-aortic balloon pump (IABP), Impella devices, and extracorporeal life support (ECLS) circuits. They are transcutaneous or surgically implanted, utilized for up to 30 days and can either assist or totally replace cardiac function, providing time for myocardial healing (bridge to recovery) or treatment escalation (bridge to destination therapy, bridge to transplantation). In light of the recently published joint consensus of the Perioperative Quality Initiative and Enhanced Recovery After Surgery Cardiac Society on temporary mechanical circulatory support, purpose of the current review is to provide a succinct head-to-head comparison of widely available devices, as well as current escalation, de-escalation and antithrombotic protocols; thus, it proposes immediately translatable device selection and operation algorithms to medical professionals for optimal patient care and effective management of cardiogenic shock.
- 8 May 2025
- Published by SAGE Publications in Perfusion
- Vol. 41 (1) , 69-79
The value of cerebral and somatic near-infrared spectroscopy within an integrated tissue perfusion monitoring strategy in cardiac surgery: A prospective pilot study
Introduction: We sought to evaluate cerebral and somatic oximetry in an integrated tissue perfusion monitoring strategy. Method: Thirty adult patients undergoing full-spectrum cardiac surgery with Minimal Invasive Extracorporeal Circulation (MiECC) were recruited. We simultaneously assessed the adequacy of tissue perfusion with near-infrared spectroscopy (NIRS) for cerebral and tissue oximetry, cerebral autoregulation monitoring (COx), sublingual microcirculation with video microscopy and real-time in-line metabolic monitoring during cardiopulmonary bypass. The primary endpoint of the study was to evaluate the diagnostic accuracy of NIRS cerebral desaturation in predicting a global perfusion-related adverse clinical event. Results: Cerebral oximetry showed the higher positive and negative predicting values (50% and 67%, respectively) in detecting a tissue perfusion-related adverse outcome. Somatic oximetry was related to higher values compared to cerebral ( p < .001) and followed a different trend. ROC analysis calculated a cutoff value of 22 for right-sided cerebral desaturation and 32 for cumulative left- and right-sided desaturation as a sensitive predictor of hyperlactemia. Microcirculatory parameters were impaired after induction of anesthesia, while they were preserved during cardiopulmonary bypass. Conclusions: NIRS cerebral oximetry represents a useful tissue perfusion monitoring tool. An AUC cutoff value of 22 for a single hemisphere and 32 bilaterally correlate with hyperlactemia and may serve as alarm for prompt action.
- 8 May 2025
- Published by SAGE Publications in Perfusion
- Vol. 41 (1) , 69-79
The value of cerebral and somatic near-infrared spectroscopy within an integrated tissue perfusion monitoring strategy in cardiac surgery: A prospective pilot study
Introduction: We sought to evaluate cerebral and somatic oximetry in an integrated tissue perfusion monitoring strategy. Method: Thirty adult patients undergoing full-spectrum cardiac surgery with Minimal Invasive Extracorporeal Circulation (MiECC) were recruited. We simultaneously assessed the adequacy of tissue perfusion with near-infrared spectroscopy (NIRS) for cerebral and tissue oximetry, cerebral autoregulation monitoring (COx), sublingual microcirculation with video microscopy and real-time in-line metabolic monitoring during cardiopulmonary bypass. The primary endpoint of the study was to evaluate the diagnostic accuracy of NIRS cerebral desaturation in predicting a global perfusion-related adverse clinical event. Results: Cerebral oximetry showed the higher positive and negative predicting values (50% and 67%, respectively) in detecting a tissue perfusion-related adverse outcome. Somatic oximetry was related to higher values compared to cerebral ( p < .001) and followed a different trend. ROC analysis calculated a cutoff value of 22 for right-sided cerebral desaturation and 32 for cumulative left- and right-sided desaturation as a sensitive predictor of hyperlactemia. Microcirculatory parameters were impaired after induction of anesthesia, while they were preserved during cardiopulmonary bypass. Conclusions: NIRS cerebral oximetry represents a useful tissue perfusion monitoring tool. An AUC cutoff value of 22 for a single hemisphere and 32 bilaterally correlate with hyperlactemia and may serve as alarm for prompt action.
- Open Access
- 25 March 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (4)
Minimal invasive extracorporeal circulation versus conventional cardiopulmonary bypass in cardiac surgery: a contemporary systematic review and meta-analysis
OBJECTIVES: The question whether minimally invasive extracorporeal circulation (MiECC) represents the optimal perfusion strategy in cardiac surgery remains unanswered. We sought to systematically review the entire literature and thoroughly address the impact of MiECC versus conventional cardiopulmonary bypass (cCPB) on adverse clinical outcomes after cardiac surgery. METHODS: We searched PubMed, Scopus and Cochrane databases for appropriate articles as well as conference proceedings from major congresses up to 31 August 2024. All randomized controlled trials (RCTs) that fulfilled pre-defined MiECC criteria were included in the analysis. The primary outcome was mortality, while morbidity and transfusion requirements were secondary outcomes. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool. All studies meeting the outcomes of interest of this systematic review were eligible for synthesis. RESULTS: Of the 738 records identified, 36 RCTs were included in the meta-analysis with a total of 4849 patients. MiECC was associated with significantly reduced mortality [odds ratio (OR) 0.66; 95% confidence interval (CI) 0.53–0.81; P = 0.0002; I2 = 0%] as well as risk of postoperative myocardial infarction (OR 0.42; 95% CI 0.26–0.68; P = 0.002; I2 = 0%) and cerebrovascular events (OR 0.55; 95% CI 0.37–0.80; P = 0.007; I2 = 0%). Moreover, MiECC reduced RBC transfusion requirements, blood loss and rate of re-exploration for bleeding together with incidence of atrial fibrillation. This resulted in significantly reduced duration of mechanical ventilation, ICU and hospital stay. CONCLUSIONS: This meta-analysis provides robust evidence for the beneficial effect of MiECC in reducing postoperative morbidity and mortality after cardiac surgery and prompts for a wider adoption of this technology.
- 25 March 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (4)
Open AccessMinimal invasive extracorporeal circulation versus conventional cardiopulmonary bypass in cardiac surgery: a contemporary systematic review and meta-analysis
OBJECTIVES: The question whether minimally invasive extracorporeal circulation (MiECC) represents the optimal perfusion strategy in cardiac surgery remains unanswered. We sought to systematically review the entire literature and thoroughly address the impact of MiECC versus conventional cardiopulmonary bypass (cCPB) on adverse clinical outcomes after cardiac surgery. METHODS: We searched PubMed, Scopus and Cochrane databases for appropriate articles as well as conference proceedings from major congresses up to 31 August 2024. All randomized controlled trials (RCTs) that fulfilled pre-defined MiECC criteria were included in the analysis. The primary outcome was mortality, while morbidity and transfusion requirements were secondary outcomes. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool. All studies meeting the outcomes of interest of this systematic review were eligible for synthesis. RESULTS: Of the 738 records identified, 36 RCTs were included in the meta-analysis with a total of 4849 patients. MiECC was associated with significantly reduced mortality [odds ratio (OR) 0.66; 95% confidence interval (CI) 0.53–0.81; P = 0.0002; I2 = 0%] as well as risk of postoperative myocardial infarction (OR 0.42; 95% CI 0.26–0.68; P = 0.002; I2 = 0%) and cerebrovascular events (OR 0.55; 95% CI 0.37–0.80; P = 0.007; I2 = 0%). Moreover, MiECC reduced RBC transfusion requirements, blood loss and rate of re-exploration for bleeding together with incidence of atrial fibrillation. This resulted in significantly reduced duration of mechanical ventilation, ICU and hospital stay. CONCLUSIONS: This meta-analysis provides robust evidence for the beneficial effect of MiECC in reducing postoperative morbidity and mortality after cardiac surgery and prompts for a wider adoption of this technology.
- 27 November 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (6) , 1527-1528
Letter re: The COMICS trial: Randomization to MiECC significantly decreases serious adverse events
- 27 November 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (6) , 1527-1528
Letter re: The COMICS trial: Randomization to MiECC significantly decreases serious adverse events
- 1 August 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (4) , 923-932
Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial
Introduction: The ultimate answer to the question whether minimal invasive extracorporeal circulation (MiECC) represents the optimal perfusion technique in contemporary clinical practice remains elusive. The present study is a real-world study that focuses on specific perfusion-related clinical outcomes after cardiac surgery that could potentially be favourably affected by MiECC and thereby influence the future clinical practice. Methods: The MiECS study is an international, multi-centre, two-arm randomized controlled trial. Patients undergoing elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or combined procedure (CABG + AVR) using extracorporeal circulation will be randomized to MiECC or contemporary conventional cardiopulmonary bypass (cCPB). Use of optimized conventional circuits as controls is acceptable. The study design includes a range of features to prevent bias and is registered at clinicaltrials.gov (NCT05487612). Results: The primary outcome is a composite of postoperative serious adverse events that could be related to perfusion technique occurring up to 30 days postoperatively. Secondary outcomes include use of blood products, ICU and hospital length of stay (30 days) as well as health-related quality of life (30 and 90 days). Conclusions: The MiECS trial has been designed to overcome perceived limitation of previous trials of MiECC. Results of the proposed study could affect current perfusion practice towards advancement of patient care.
- 1 August 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (4) , 923-932
Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial
Introduction: The ultimate answer to the question whether minimal invasive extracorporeal circulation (MiECC) represents the optimal perfusion technique in contemporary clinical practice remains elusive. The present study is a real-world study that focuses on specific perfusion-related clinical outcomes after cardiac surgery that could potentially be favourably affected by MiECC and thereby influence the future clinical practice. Methods: The MiECS study is an international, multi-centre, two-arm randomized controlled trial. Patients undergoing elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or combined procedure (CABG + AVR) using extracorporeal circulation will be randomized to MiECC or contemporary conventional cardiopulmonary bypass (cCPB). Use of optimized conventional circuits as controls is acceptable. The study design includes a range of features to prevent bias and is registered at clinicaltrials.gov (NCT05487612). Results: The primary outcome is a composite of postoperative serious adverse events that could be related to perfusion technique occurring up to 30 days postoperatively. Secondary outcomes include use of blood products, ICU and hospital length of stay (30 days) as well as health-related quality of life (30 and 90 days). Conclusions: The MiECS trial has been designed to overcome perceived limitation of previous trials of MiECC. Results of the proposed study could affect current perfusion practice towards advancement of patient care.